Arax Advisory Partners’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
Arax Advisory Partners's GH Position: Q3 2026 in Review
Arax Advisory Partners increased its Guardant Health (GH) stake by 9% in Q3 2026, buying an estimated $12.6K and bringing the position to 931 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #2447.
Arax Advisory Partners first reported a position in GH in Q1 2020 and has held it in 26 quarters since. 673 funds tracked by Wall St. Rank hold GH as of Q3 2026.
- Arax Advisory Partners held 931 shares of Guardant Health worth $166K as of Q3 2026.
- Arax Advisory Partners bought 77 Guardant Health shares in Q3 2026, an estimated $12.6K.
- Guardant Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #2447 holding.
- Arax Advisory Partners first reported a position in Guardant Health in Q1 2020 and has held it in 26 quarters since.
- 673 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.